“No Clinically Significant Association Between Cfh And Arms2 Genotypes And Response To Nutritional Supplements: Areds Report Number 38.”. Ophthalmology 121 (11). Ophthalmology: 2173-80. doi:10.1016/j.ophtha.2014.05.008.
. 2014. “{Omega}-3 Long-Chain Polyunsaturated Fatty Acid Intake And 12-Y Incidence Of Neovascular Age-Related Macular Degeneration And Central Geographic Atrophy: Areds Report 30, A Prospective Cohort Study From The Age-Related Eye Disease Study.”. Am J Clin Nutr 90 (6). Am J Clin Nutr: 1601-7. doi:10.3945/ajcn.2009.27594.
. 2009. “Omega-3 Long-Chain Polyunsaturated Fatty Acid Intake Inversely Associated With 12-Year Progression To Advanced Age-Related Macular Degeneration.”. Arch Ophthalmol 127 (1). Arch Ophthalmol: 110-2. doi:10.1001/archophthalmol.2008.518.
. 2009. “Prevalence, Risk, And Genetic Association Of Reticular Pseudodrusen In Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”. Ophthalmology 126 (12). Ophthalmology: 1659-1666. doi:10.1016/j.ophtha.2019.07.022.
. 2019. “The Relationship Of Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Intake With Incident Age-Related Macular Degeneration: Areds Report No. 23.”. Arch Ophthalmol 126 (9). Arch Ophthalmol: 1274-9. doi:10.1001/archopht.126.9.1274.
. 2008. “Retinal Specialist Versus Artificial Intelligence Detection Of Retinal Fluid From Oct: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”. Ophthalmology. Ophthalmology. doi:10.1016/j.ophtha.2020.06.038.
. 2020. “Risk Factors Associated With Incident Cataracts And Cataract Surgery In The Age-Related Eye Disease Study (Areds): Areds Report Number 32.”. Ophthalmology 118 (11). Ophthalmology: 2113-9. doi:10.1016/j.ophtha.2011.03.032.
. 2011. “Secondary Analyses Of The Effects Of Lutein/zeaxanthin On Age-Related Macular Degeneration Progression: Areds2 Report No. 3.”. Jama Ophthalmol 132 (2). Jama Ophthalmol: 142-9. doi:10.1001/jamaophthalmol.2013.7376.
. 2014. “Ten-Year Follow-Up Of Age-Related Macular Degeneration In The Age-Related Eye Disease Study: Areds Report No. 36.”. Jama Ophthalmol 132 (3). Jama Ophthalmol: 272-7. doi:10.1001/jamaophthalmol.2013.6636.
. 2014. “Ten-Year Incidence Rates Of Age-Related Cataract In The Age-Related Eye Disease Study (Areds): Areds Report No. 33.”. Ophthalmic Epidemiol 20 (2). Ophthalmic Epidemiol: 71-81. doi:10.3109/09286586.2012.759598.
. 2013. “Visual Acuity After Cataract Surgery In Patients With Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5.”. Ophthalmology 121 (6). Ophthalmology: 1229-36. doi:10.1016/j.ophtha.2013.12.035.
. 2014. “Visual Acuity Outcomes After Anti-Vascular Endothelial Growth Factor Treatment For Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”. Ophthalmol Retina 4 (1). Ophthalmol Retina: 3-12. doi:10.1016/j.oret.2019.06.001.
. 2020. “Visual Acuity Outcomes After Cataract Surgery In Patients With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 27.”. Ophthalmology 116 (11). Ophthalmology: 2093-100. doi:10.1016/j.ophtha.2009.04.033.
. 2009.